Who Owns Scinai Immunotherapeutics Stock?
NASDAQ: SCNIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 11:48 AM ET
Ownership breakdown
- Held by institutions
- 3.33%
- Held by insiders
- 14.16%
- Institutional holders
- 11
- Institutions 3.3%
- Insiders 14.2%
- Public and other 82.5%
Who owns Scinai Immunotherapeutics stock?
Institutional investors own about 3.3% of Scinai Immunotherapeutics's shares, spread across 11 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 14.16% of SCNI.
The largest institutional holders are Citadel Advisors Llc (0.88%), Armistice Capital, LLC (0.51%) and Virtu Financial LLC (0.28%). Together, the top 10 institutions control 2.7% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their SCNI positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SCNI
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Citadel Advisors Llc | 6.23K | 0.88% | +100.0% |
| Armistice Capital, LLC | 3.59K | 0.51% | +100.0% |
| Virtu Financial LLC | 1.95K | 0.28% | +100.0% |
| Xtx Topco Ltd | 1.68K | 0.24% | -30.3% |
| Rhumbline Advisers | 1.35K | 0.19% | +618.6% |
| Stonex Group Inc. | 1.31K | 0.19% | +100.0% |
| HRT Financial LP | 1.21K | 0.17% | +100.0% |
| CAPTRUST Financial Advisors | 1.20K | 0.17% | +100.0% |
| UBS Group AG | 396 | 0.06% | +330.4% |
| Royal Bank of Canada | 82 | 0.01% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SCNI
| Fund | Shares | % Held |
|---|---|---|
| SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E | 2 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Scinai Immunotherapeutics?
Citadel Advisors Llc is the largest institutional shareholder of SCNI, owning 0.88% of shares outstanding (6.23K shares) as of its latest 13F filing.
What percentage of Scinai Immunotherapeutics is owned by institutions?
Institutions own about 3.3% of SCNI shares and 3.9% of the public float.
How much of Scinai Immunotherapeutics do insiders own?
Insiders, such as officers and directors, own about 14.16% of SCNI shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.